Your browser doesn't support javascript.
loading
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.
Cabel, Luc; Fuerea, Alina; Lacroix, Ludovic; Baldini, Capucine; Martin, Patricia; Hollebecque, Antoine; Postel-Vinay, Sophie; Varga, Andrea; Balheda, Rastilav; Gazzah, Anas; Michot, Jean-Marie; Marabelle, Aurélien; Rouleau, Etienne; Solary, Eric; De Baere, Thierry; Angevin, Eric; Armand, Jean-Pierre; Michiels, Stefan; Scoazec, Jean Yves; Ammari, Samy; André, Fabrice; Soria, Jean-Charles; Massard, Christophe; Verlingue, Loic.
Afiliación
  • Cabel L; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Fuerea A; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Lacroix L; Laboratory of Translational Research and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655 Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Baldini C; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Martin P; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Hollebecque A; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Postel-Vinay S; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Varga A; Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Balheda R; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Gazzah A; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Michot JM; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Marabelle A; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Rouleau E; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Solary E; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • De Baere T; Laboratory of Translational Research and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655 Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Angevin E; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Armand JP; Inserm Unit UMR 1170, Université Paris Saclay, Université Paris-Sud, Gustave Roussy, Villejuif, France.
  • Michiels S; Department of Interventional Radiology, Gustave Roussy, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Scoazec JY; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • Ammari S; Drug Development Department (DITEP), Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Villejuif, France.
  • André F; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Villejuif, France.
  • Soria JC; Laboratory of Translational Research and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655 Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Massard C; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Verlingue L; Department of Radiology, Gustave Roussy, Faculté de Medicine Paris-Sud XI, Villejuif, France.
Oncotarget ; 9(11): 9741-9750, 2018 Feb 09.
Article en En | MEDLINE | ID: mdl-29515767
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia